Effects of Telmisartan Added to Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Hemodialysis Patients With Chronic Heart Failure : A Double-Blind, Placebo-Controlled Trial
Keywords: CHF، نارسایی قلبی مزمن; chronic heart failure; dialysis; mortality; telmisartanACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II type 1 receptor blocker; BB, beta-blocker; CHF, chronic heart failure; CI, confidence interval; ESRD, end-stage renal disease; HR, h